Screener
Tarsus Pharmaceuticals, Inc. TARS Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense), net | (281) | (145) | (368) | (226) |
| Total other income (expense), net | 4,073 | 1,844 | 5,580 | 3,004 |
| Provision for income taxes | (2,716) | — | (5,068) | — |
| Net loss | $(18,551) | $(20,340) | $(25,518) | $(45,460) |
| Unrealized gain (loss) on marketable securities and cash equivalents | (259) | (46) | (938) | (140) |
| Comprehensive loss | $(18,810) | $(20,386) | $(26,456) | $(45,600) |
| Net loss per share, basic and diluted | $(0.43) | $(0.48) | $(0.59) | $(1.11) |
| Weighted-average shares outstanding, basic and diluted | 43,393,643 | 42,360,452 | 43,176,514 | 40,869,364 |
Item 1. Financial Statements
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s net income?
- Tarsus Pharmaceuticals, Inc. (TARS) reported net income of -$18.55M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s net income changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s net income increased by 8.8% year-over-year, from -$20.34M to -$18.55M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s net income?
- Over 4 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s net income has grown at a 48.0% compound annual growth rate (CAGR), from -$13.83M to -$66.42M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude